August 2026 - New Chemotherapy-Free Immunotherapy Combination for Follicular Lymphoma Listed on the PBS

The PBS listing of Minjuvi marks the availability of the first and only chemotherapy-free CD19 and CD20 dual-targeted immunotherapy combination regimen funded in Australia for this group of patients.